Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating (NASDAQ:FLGT)
Fulgent Genetics, Inc. ( FLGT ) stock is trading at its 52-week highs after a solid double-digit gain over the past month. This significant growth followed its release of exciting Q3 numbers earlier in November, which saw hugeGamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, capital markets, and the macro-economy, Gamu has ...